Freestone Grove Partners »

Bio-Rad Laboratories shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $18M 74k 241.32
2024-12-31 $15M 46k 328.51

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Weyerhaeuser Co Mtn Be Com New (WY)
Cintas Corporation (CTAS)
MasTec (MTZ)
Microsoft Corporation (MSFT)
EOG Resources (EOG)
KB Home (KBH)
First Horizon National Corporation (FHN)
Netflix (NFLX)
Procter & Gamble Company (PG)
At&t (T)
Twilio Cl A (TWLO)
3M Company (MMM)
Vulcan Materials Company (VMC)

View all positions for Freestone Grove Partners

Top funds holding Bio-Rad Laboratories

First Eagle Investment Management
Vanguard Group
BlackRock
Dimensional Fund Advisors
Veritas Asset Management
Ariel Investments
Earnest Partners
State Street Corporation
Capital Research Global Investors
Ubs Global Asset Management Americas
First Pacific Advisors
Geode Capital Management
Parnassus Investments
Sei Investments
Mawer Investment Management

View all funds holding Bio-Rad Laboratories